Damien Portevin

TB immunology researcher @SwissTPH.

[bioRxiv Microbiology @biorxiv_micrbio]

Bacterial diversity dominates variable macrophage responses of tuberculosis patients in Tanzania https://t.co/7stTEnGmNh #biorxiv_micrbio

[Damien Portevin @DPortevin]

I'm looking for a motivated post-doc eager to unravel the immunological aspects of subclinical TB using our 3D granuloma model and clinical strains and specimen from patients, please spread the word, thx! https://t.co/Py5anxMoB6

[PathoGenOmics @Patho_Gen_Omics]

We are looking for a junior postdoc! Anyone interested in studying in vitro virulence of different mycobacterial tuberculosis strains in different hosts? Experience in metabolomics, infection biology or sequence analysis will be considered. [email protected]

[Damien Portevin @DPortevin]

Opened position to support my "TB immunology" research group in Basel, Switzerland
https://t.co/ZxgBgN1iuQ

[Ludovic Desvignes @elyoudeeoh]

Vaccine Pass announcement in July resulted in a massive spike in appointments in France. And two months later, it pays off. Continental France has curtailed its 4th wave. Vaccines control viral spread (and hospitalizations/deaths) and vaccine mandates work.

[Damien Portevin @DPortevin]

@FvLScience Thank you for asking. This assessment was performed live in a dense urban setting in Tanzania where it is definitely needed.

[Damien Portevin @DPortevin]

Really excited to have our latest effort to develop a sputum independent test to diagnose TB within 24h by flow cytometry on the cloud! ;-) https://t.co/bTyRKRsh7I

[PathoGenOmics @Patho_Gen_Omics]

Nice granuloma model to study Mtb dormancy presented by Ainhoa Arbues (@swisstph and with @DPortevin) during the #myconet webinar. https://t.co/esYcx9VJPK